title: Breath biomarkers in toxicology.
abstract: Exhaled breath has joined blood and urine as a valuable resource for sampling and analyzing biomarkers in human media for assessing exposure, uptake metabolism, and elimination of toxic chemicals. This article focuses current use of exhaled gas, aerosols, and vapor in human breath, the methods for collection, and ultimately the use of the resulting data. Some advantages of breath are the noninvasive and self-administered nature of collection, the essentially inexhaustible supply, and that breath sampling does not produce potentially infectious waste such as needles, wipes, bandages, and glassware. In contrast to blood and urine, breath samples can be collected on demand in rapid succession and so allow toxicokinetic observations of uptake and elimination in any time frame. Furthermore, new technologies now allow capturing condensed breath vapor directly, or just the aerosol fraction alone, to gain access to inorganic species, lung pH, proteins and protein fragments, cellular DNA, and whole microorganisms from the pulmonary microbiome. Future applications are discussed, especially the use of isotopically labeled probes, non-targeted (discovery) analysis, cellular level toxicity testing, and ultimately assessing "crowd breath" of groups of people and the relation to dose of airborne and other environmental chemicals at the population level.
authors: Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, USA. pleil.joachim@epa.gov.
authors: Joachim D
authors: JD
authors: Pleil
mesh_terms: D000336:Aerosols / Q000737:chemistry; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D035843:Biomedical Research / Q000295:instrumentation / Q000379:methods / Q000639:trends; D001944:Breath Tests / Q000295:instrumentation / Q000379:methods; D004781:Environmental Exposure / Q000009:adverse effects*; D018876:Environmental Illness / Q000139:chemically induced / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D004785:Environmental Pollutants / Q000378:metabolism / Q000633:toxicity*; D006292:Health Priorities / Q000639:trends; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D008904:Miniaturization / Q000295:instrumentation / Q000379:methods; D010316:Particle Size; D066007:Toxicokinetics; D014116:Toxicology / Q000295:instrumentation / Q000379:methods* / Q000639:trends; D014835:Volatilization
chemical_list: D000336:Aerosols; D015415:Biomarkers; D004785:Environmental Pollutants
keywords: Adverse outcome pathway; Breath condensate; Cellular respiration; Exhaled breath; Human exposome; Mass spectrometry